Tibra Equities Europe’s Select Medical SEM Stock Holding History

Tibra Equities Europe’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-74,426	Closed	-$565K	–	409
2019 Q1	$565K	Buy	+74,426	New	+$598K	0.06%	252
2018 Q1	–	Sell	-36,808	Closed	-$350K	–	254
2017 Q4	$350K	Buy	+36,808	New	+$352K	0.15%	107

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Tibra Equities Europe's SEM Position: Q2 2019 in Review

Tibra Equities Europe sold out of Select Medical (SEM) in Q2 2019, closing a stake of 74,426 shares — an estimated $565K sold.

Tibra Equities Europe first reported a position in SEM in Q4 2017 and held it in 2 quarters. The position peaked at $565K in Q1 2019. 194 funds tracked by Wall St. Rank hold SEM as of Q2 2019.

Tibra Equities Europe reported no remaining Select Medical position as of Q2 2019 after selling out during the quarter.
Tibra Equities Europe sold 74,426 Select Medical shares in Q2 2019, an estimated $565K.
Tibra Equities Europe first reported a position in Select Medical in Q4 2017 and held it in 2 quarters.
Tibra Equities Europe's Select Medical position peaked at $565K in Q1 2019.
194 funds tracked by Wall St. Rank held Select Medical as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.